News

11 de April de 1880

  • Kasznar Leonardos

Regulatory Law in the Health Area

Our Regulatory team anticipates and prepares your company with regard to the sector’s challenges and opportunities.

We act within the scope of competence of the rule-making entities towards the feasibility of commercialization of products and services, as well as the authorization of licensing of operations, including the approval of projects, registration of products and securing import licenses. We also participate most actively in workgroups, associations and events, in addition to monitoring all legislation updates.

We provide consultancy and litigation services and we act at all times of interaction with the health authorities, particularly the Brazilian Health Supervision Agency [ANVISA – Agência Nacional de Vigilância Sanitária] and the Brazilian Complementary Health [Private Health Insurance] Agency [ANS – Agência Nacional de Saúde Complementar].

Ours is a multidisciplinary approach, with actions carried out together with other fields – such as intellectual property, public law and anti-corruption practices, to better provide assistance to your business in strategic matters throughout the entire life cycle of your products, irrespective of the latter consisting in medicaments, biological products, medical devices, foodstuffs, cosmetic products, sanitation products or agrochemical products.

Back

Last related news

9 de December de 2025

Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

For years, the most common form of software piracy involved downloading cracked or unauthorized versions from websites offering them for free. Although Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

  • Kasznar Leonardos
  • Ler notícia

    25 de November de 2025

    Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

    Kasznar Leonardos is pleased to announce an important victory before the São Paulo Court of Appeals in a software license compliance action Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

  • Kasznar Leonardos
  • Ler notícia

    13 de November de 2025

    ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

    The National Health Surveillance Agency (Anvisa) published on Monday, November 10, 2025, the Collegiate Board Resolution (RDC) No. 997/2025, which institutes exceptional ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

  • Kasznar Leonardos
  • Ler notícia